Zinc Patents (Class 514/494)
-
Publication number: 20100152288Abstract: Provided are novel ?-lipoic acid derivatives represented by the following formula (I), which have a tyrosinase inhibiting activity, a melanin production suppressing activity and an elastase inhibiting activity. (In the formula, M denotes a metal, and A denotes an amino acid which is bound via N.Type: ApplicationFiled: March 1, 2010Publication date: June 17, 2010Applicant: Senju Pharmaceutical Co. Ltd.Inventors: Kazumi OGATA, Takahiro Sakaue, Kazuhiko Ito
-
Publication number: 20100144870Abstract: Bimetal chelates are prepared from a solution formed by adding to a solvent one or more polyfunctional acids with basic salts of two or more coordination elements listed in Groups IIIA to VIIIA, Groups IB to IIIB, of periods 4 and 5 and aluminum in Group IIIB, period 3 of The Periodic Table of the Elements and recovering the chelate. Such chelates can be used to formulate useful products.Type: ApplicationFiled: February 19, 2010Publication date: June 10, 2010Applicant: JR CHEM, LLCInventors: Jose E. Ramirez, Joseph Faryniarz
-
Publication number: 20100119608Abstract: Among natural mechanisms of cell deaths, disease or toxicity, one of the most common method is through overloading of certain biological metals such as calcium, iron and zinc. We propose to utilize this natural mechanism of cell death against cancer by utilizing the well known phenomenon of enhanced permeation and retention effect (EPR effect) and metal-binding nanoparticle moieties that can self-degrade under certain biological conditions such as pH. More specifically, we show that one can form nanoparticles that consist of polymerized citric acid and various different types of metals including, but not limited to, iron, calcium, zinc, silver and magnesium, displaying acid-stability and self-degradation leading to constituent metal release when pH rises closer to the neutral pH of 7 or higher.Type: ApplicationFiled: November 11, 2008Publication date: May 13, 2010Inventor: Jinhyuk Fred Chung
-
Publication number: 20100098752Abstract: Compositions and methods for administering one or more antioxidants to a human subject have been developed. The antioxidant-containing lipid vesicles of the invention provide a delivery system for antioxidants which can be applied topically to the skin.Type: ApplicationFiled: January 18, 2008Publication date: April 22, 2010Inventor: Mark A. Pinsky
-
Skin care composition for accelerated production of collagen proteins and method of fabricating same
Patent number: 7700083Abstract: A liquid solution for topical application to the skin of an animal consists of solutes and a solvent, where the solutes include ascorbate, tropocollagen factors, copper, and zinc gluconate. The tropocollagen factors include L-proline, glycine and L-lysine.Type: GrantFiled: August 3, 2006Date of Patent: April 20, 2010Inventor: Kevin Meehan -
Publication number: 20100093850Abstract: Provided is a composition for accelerating absorption of metals, comprising a metal-acidic amino acid chelate as an active ingredient. The composition of the present invention has therapeutic effects on prevention and treatment of various diseases arising from a deficiency or shortage of metals, by utilization of a metal-acidic amino acid chelate that exhibits excellent effects of improving delivery and absorption of a drug into target organs, such that pharmaceutical effects of individual metals can be exerted. In particular, a pharmaceutical composition comprising a zinc-aspartate chelate increasing an intraprostatic zinc content as an active ingredient is highly effective for prevention and treatment of prostate and testicular diseases.Type: ApplicationFiled: June 29, 2007Publication date: April 15, 2010Inventor: Myunggyu Park
-
Patent number: 7695732Abstract: The invention pertains to a method of treating or preventing pressure ulcers, comprising enterally administering to a subject in need thereof a composition comprising proteins, carbohydrates, fats, arginine or equivalents thereof, ascorbic acid equivalents and ?-tocopherol equivalents, wherein arginine or equivalents thereof is administered in a daily amount of 3-15 g, ascorbic acid equivalents are administered in a daily amount of 180-840 mg and ?-tocopherol equivalents are administered in a daily amount of 50-400 mg.Type: GrantFiled: November 22, 2004Date of Patent: April 13, 2010Assignee: N.V. NutriciaInventors: Maria Anna Verheul-Koot, Chantal Nelleke Kleijer, Robert Johan Joseph Hageman, Roelof Andre Bork, Maud Goethals
-
Patent number: 7687077Abstract: A method is provided for reducing stool odor of a companion animal such as a cat or dog. The method comprises causing the animal to ingest a composition comprising a stool odor reducing effective amount of a zinc ion source, for example zinc acetate.Type: GrantFiled: November 24, 2004Date of Patent: March 30, 2010Assignee: Hill's Pet Nutrition, Inc.Inventors: Christina Khoo, Dale Scherl
-
Patent number: 7683193Abstract: Benzolipoxin analogs, methods of their preparation and pharmaceutical compositions containing the compounds are provided. The compounds and compositions are useful in methods for treatment of various diseases, including, inflammation, autoimmune disease and abnormal cell proliferation.Type: GrantFiled: April 4, 2006Date of Patent: March 23, 2010Assignee: University of Southern CaliforniaInventor: Nicos A. Petasis
-
Patent number: 7662222Abstract: This invention relates to the use of a combination of selected substances in paint to prevent the settlement and growth of different biofouling organisms with a reduced negative effect on the ecosystems compared to present methods.Type: GrantFiled: June 23, 2009Date of Patent: February 16, 2010Assignee: I-Tech ABInventors: Magnus Nydén, Camilla Fant
-
Patent number: 7652161Abstract: A method of providing zinc to a subject in need of treatment includes administering to the subject an effective amount of a zinc-cysteine complex. The zinc-cysteine complex is preferably a zinc-monocysteine complex. The complexes of zinc-cysteine of the present invention increase the activity of antioxidant enzymes catalase and glutathione peroxidase, and the antioxidant protein metallothionein. The complexes of zinc-cysteine of the present invention protect retinal pigment epithelial cells from increasing hydrogen peroxide concentrations.Type: GrantFiled: January 9, 2007Date of Patent: January 26, 2010Inventors: David A. Newsome, David Tate
-
Publication number: 20090317486Abstract: A composition for the treatment of a liquid, particularly a body of water, such as a swimming pool, spa, or the like. The composition includes calcium hypochlorite, a water soluble zinc salt for controlling algae, and sodium aluminate as an agglomerating agent that may safely be combined with said calcium hypochlorite and said zinc salt. A floating chemical dispenser for containing and dispensing chemicals to treat a body of water. The dispenser includes an upper end float, a container adapted to contain chemicals, the container removably joined with the upper end float, and a free end float joined with the container. The free end float is configured so that a central axis of the container and upper end float is not substantially orthogonal to a surface of the water.Type: ApplicationFiled: August 26, 2009Publication date: December 24, 2009Applicant: ARCH CHEMICALS, INC.Inventors: Peter Kenneth Hodgetts, Richard M. Mullins
-
Publication number: 20090291110Abstract: An improved anti-bacteria wipe for cleansing and drying toilet seats in public restrooms that is biodegradable and destroys germs and bacteria on contact. The wipe is comprised of four layers. The sealing first layer in conjunction with the third layer contains the moisture of the second layer. The pre-moistened second layer is infused with a quick drying anti-bacteria solution that kills germs and bacteria on contact. The third layer is an ultra thin biodegradable plastic to prevent seepage between the second and fourth layers. The fourth layer is a dry absorbent material used to remove any remaining moisture from the toilet seat. The wipe is sealed in an outer pouch to maximize shelf life. The biodegradable wipe can easily and safely be disposed of following use with reduced environmental impact.Type: ApplicationFiled: May 15, 2008Publication date: November 26, 2009Inventors: Colbert Johnson, Velma Johnson
-
Publication number: 20090285865Abstract: Palatable, solid oral formulations or compositions include at least one bioactive agent capable of chemical sterilization of human and animal males. Depending on the targeted species, the bioactive formulations comprise suitable additives, excipients, water-swellable compositions, and/or processing aids and can be made into uncoated or coated forms to modulate the release profile of the bioactive agents. Among the bioactive agents are zinc compounds and complexes and organic drugs with established pharmacological activities, which are traditionally unrelated to any form of contraception.Type: ApplicationFiled: May 14, 2009Publication date: November 19, 2009Inventor: Shalaby W. Shalaby
-
Publication number: 20090285770Abstract: The invention relates in particular to a composition for topical application to the skin, comprising, in a physiologically acceptable medium, at least one peptide increasing the expression of mechanoreceptors in the cells of the skin and at least one tensing agent. According to one alternative the agent increasing the expression of mechanoreceptors in the cells of the skin is selected from zinc salts, copper salts, manganese salts, derivatives thereof and mixtures thereof. The invention likewise relates to a skincare kit comprising at least two compositions comprising respectively the tensing agent and the agent increasing the expression of mechanoreceptors in the cells of the skin. The invention also relates to a method of cosmetic treatment of the skin that comprises simultaneous or sequential application of said compositions.Type: ApplicationFiled: November 17, 2006Publication date: November 19, 2009Applicant: L'OrealInventor: Julien Laboureau
-
Publication number: 20090239946Abstract: The present invention provides pharmaceutical compositions of an HDAC inhibitor and a chelatable metal compound. In one embodiment, the invention provides a method of treating cancer and alleviating the side effects of the HDAC inhibitor by administering the pharmaceutical composition. In another embodiment, the present invention also provides pharmaceutical compositions of metal HDAC inhibitor chelate complexes. In another embodiment, the invention provides methods of treating cancer by administering the pharmaceutical compositions. The invention provides crystalline compositions of metal HDAC inhibitor chelate complexes and methods of producing same.Type: ApplicationFiled: September 24, 2007Publication date: September 24, 2009Inventors: Arlene E. McKeown, Thomas A. Miller
-
Publication number: 20090215889Abstract: The invention relates to a novel therapeutic use of zinc gluconate. The zinc gluconate is used in a form for oral administration, at a daily dosage of between 45 and 125 mg, for treating suppurative hidradenitis, or Verneuil's disease.Type: ApplicationFiled: April 6, 2006Publication date: August 27, 2009Applicant: LABCATALInventors: Catherine Suck, Brigitte Dreno, Jacques Bodin
-
Publication number: 20090209642Abstract: This invention relates to certain divalent or polyvalent metals of first transition series of the Periodic Table of Elements and including zinc and Molybdenum, complexed concurrently with an amino acid and a hydroxy acid in a novel spirocyclic bidentate chemical complex form (FIG. 1). Upon topical application said metal complexes undergo enhanced skin penetration without causing skin irritation.Type: ApplicationFiled: April 10, 2009Publication date: August 20, 2009Applicant: BIODERM RESEARCHInventor: SHYAM K. GUPTA
-
Publication number: 20090202448Abstract: The present invention relates to a method for the preparation of a new metal lactate powdery product and to the resulting product itself with new properties. The metal lactate powder of the present invention is made via spray-drying and has a higher flowability, is less sticky and dusty, has an improved dissolution rate and is very suited for tabletting purposes. The invention is also directed to product applications in which said spray-dried metal lactate product may be applied, wherein the metal is selected from zinc and magnesium.Type: ApplicationFiled: February 6, 2009Publication date: August 13, 2009Applicant: PURAC BIOCHEM B.V.Inventors: Marcus J.A.W. Vorage, Martijn Janissen
-
Patent number: 7569558Abstract: The present invention relates to a method for topical delivery of trace metals for the modulation of certain metalloenzymes. The method of topical delivery of the present invention comprises; (i) mixing of a trace metal salt of a phosphorylated nitrogen heterocyclic base complexed with a chelating agent [Figure l], and (ii) a carrier, and (iii) topical application of said mixture. The modulation of metalloenzymes such as Superoxide Dismutase, Elastase, Tyrosinase, Matrix metalloproteases, and Ubiquitin-Proteasome pathway by the methods of the present invention is useful for providing anti-inflammatory, skin whitening, wrinkles reduction, skin aging control, cellular antioxidant, acne control, hair growth modulation, and skin damage control benefits.Type: GrantFiled: March 15, 2006Date of Patent: August 4, 2009Assignee: Bioderm ResearchInventor: Shyam K Gupta
-
Publication number: 20090182044Abstract: The present invention is directed to methods and compositions which include nitrate amino acid chelates that can increase the metabolic activity or metal concentration in animals and that can increase metabolic activity and nitrogen content in plants. In one embodiment, a nitrate-complexed amino acid composition can comprise a metal, an amino acid ligand, and a nitrate, wherein the amino acid ligand is chelated to the metal forming an amino acid chelate and the nitrate is complexed to the amino acid chelate. In another embodiment, a nitrate-chelated amino acid composition can comprise a metal, an amino acid ligand, and a nitrate, wherein the amino acid ligand and the nitrate are chelated to the metal forming a nitrate-chelated amino acid chelate.Type: ApplicationFiled: January 9, 2009Publication date: July 16, 2009Inventors: H. DeWayne Ashmed, Charlie Thompson
-
Patent number: 7560447Abstract: The present invention relates to a preparation suitable for the prevention and/or treatment of vascular disorders, comprising the following fractions: fraction a) consisting of long chain polyunsaturated fatty acids; fraction b) consisting of phospholipids, which fraction contains at least two different phospholipids selected from the group consisting of phosphatidylserine, phosphatidylinositol, phosphatidylcholine and phosphatidylethanolamine. fraction c) consisting of compounds which are a factor in methionine metabolism, which fraction contains at least one member selected from the group consisting of folic acid, vitamin B12, vitamin B6, magnesium and zinc.Type: GrantFiled: April 27, 2007Date of Patent: July 14, 2009Assignee: N.V. NutriciaInventors: Amanda Johanne Kiliaan, Robert Johan Joseph Hageman
-
Publication number: 20090176875Abstract: A method for manufacturing a stabilized metal nano particle solution is disclosed. This method manufactures a metal nano particle solution so as to make a metal substance such as silver, gold, copper, zinc or cobalt into ultra-capsular nano particles. That is to say, this new method is simple and suitable for mass production without requiring any separate reducer putting process at a room temperature while a transition metal nano particle solution is produced. In this method, an alcohol solution including a metal salt solution and a soluble polymer is mixed at a room temperature to make a nano metal particle solution with a particle size of 100 nm or less.Type: ApplicationFiled: January 9, 2008Publication date: July 9, 2009Inventors: Dong-Pyo Kim, Yoon-Hyuck Choi, Choong G. Row
-
Publication number: 20090176876Abstract: Compositions, kits and regimens for treatment of damaged skin, especially décolletage, include application of a retinoid, hydroquinone or hydroquinone derivatives, and a composition containing a multi-metal complex.Type: ApplicationFiled: December 10, 2008Publication date: July 9, 2009Applicant: JR CHEM, LLCInventors: Jose E. Ramirez, Joseph R. Faryniarz
-
Patent number: 7550504Abstract: A process for preparing a feed supplement that promotes growth in animals by (i) preparing a dry metal carboxylate of formula M(RCOOH)2; (ii) preparing a metal aminoate; and (iii) mixing the dry metal carboxylate and the metal aminoate under conditions that form a complex including the metal carboxylate and the metal aminoate and water, then removing the water to form a dry metal complex of the metal carboxylate and the metal aminoate. When administered to an animal in its feed, a bioavailability of the divalent metal in the dry metal complex is different than the bioavailability of the divalent metal in either the dry metal carboxylate or the metal aminoate alone.Type: GrantFiled: July 9, 2004Date of Patent: June 23, 2009Assignee: Norel, S.A.Inventor: Enrique Pablos
-
Patent number: 7540906Abstract: Complexes of copper and/or zinc with hydrolyzed olefin/maleic anhydride copolymers were solubilized in ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the complexes were stably retained in the wood providing a long lasting preservative.Type: GrantFiled: December 21, 2006Date of Patent: June 2, 2009Assignee: E.I. Du Pont de Nemours & CompanyInventors: Albert Gordon Anderson, John Feaster, Damini Patel, Mark Scialdone
-
Publication number: 20090136591Abstract: A set of signature genes that predict the severity of septic shock, as well as methods of diagnosing and treating septic shock. The genes and methods are particularly useful for the identification of individuals who are at a high risk of death from septic shock.Type: ApplicationFiled: April 19, 2006Publication date: May 28, 2009Inventors: Hector R. Wong, Bruce J. Aronow, Thomas P. Shanley
-
Publication number: 20090136592Abstract: Two-phase preparation for temporally gradual administration comprising a) a phase (A) comprising water soluble vitamins and/or the corresponding provitamins, wherein phase (A) does not contain liposoluble vitamins or provitamins corresponding to liposoluble vitamins, b) a phase (B) comprising vitamins and/or the corresponding provitamins, wherein the quantity of liposoluble vitamin compounds is larger than the quantity of water soluble vitamin compounds.Type: ApplicationFiled: June 17, 2008Publication date: May 28, 2009Inventor: Tanja Lautenschlager
-
Publication number: 20090137666Abstract: Multifunctional “smart” nanostructures are disclosed that include fluorescein isothiocyanate (FITC)-encapsulated SiO2 core-shell particles with a nanoscale ZnO finishing layer, wherein an outer ZnO layer is formed on the SiO2-FITC core. These ˜200 nm sized particles showed promise toward cell imaging and cellular uptake studies using the bacterium Escherichia coli and Jurkat cancer cells, respectively. The FITC encapsulated ZnO particles demonstrated excellent selectivity in preferentially killing Jurkat cancer cells with minimal toxicity to normal primary immune cells (18% and 75% viability remaining, respectively, after exposure to 60 ?g/mL) and inhibited the growth of both gram-positive and gram-negative bacteria at concentrations ?250-500 ?g/mL (for Staphylococcus aureus and Escherichia coli, respectively).Type: ApplicationFiled: September 22, 2008Publication date: May 28, 2009Applicant: BOISE STATE UNIVERSITYInventors: Hua Wang, Denise Wingett, Kevin Feris, Madhusudan R. Kongara, Alex Punnoose
-
Patent number: 7524517Abstract: This invention relates generally to a method of increasing cytosolic Ca2+ levels in mammalian cells comprising contacting P2X receptor Ca2+ entry channels or any and all other Ca2+ entry channels or mechanisms on the cell with an effective amount of a small molecule, and a composition comprising the small molecule in a delivery system. The invention has broad applicability in the pharmaceutical industry as a method of treating airway diseases (such as cystic fibrosis and asthma), ailments of the lung and airways (such as those caused by common cold pathogens or allergens in allergy), kidney diseases and renal hypertensive disorders (such as polycystic kidney disease and salt-sensitive hypertension syndromes), and endocrine disorders (such as diabetes).Type: GrantFiled: January 20, 2004Date of Patent: April 28, 2009Assignee: UAB Research FoundationInventors: Erik Schwiebert, Akos Zsembery
-
Publication number: 20090105335Abstract: Disclosed herein are methods for the preparation of a free-flowing, storage-stable fatty acid metal salt product by forming a reactive admixture comprising (a) an unsaturated fatty acid glyceride feedstock; and (b) from about 1 mol to about 3 mol of at least one monovalent metal hydroxide or at least one divalent metal hydroxide; and heating the admixture to a temperature at which said fatty acid glycerides saponify to form fatty acid metals salts; wherein said monovalent metal is potassium; and wherein said divalent metal is selected from the group consisting of calcium, copper, magnesium and zinc. The fatty acid glycerides may be saponified in an atmosphere in which the partial pressure of oxygen has been reduced by an amount effective to provide an improvement in storage stability until a free-flowing, storage-stage product is obtained, or prior to saponification, the fatty acid glycerides may blended with a stabilizing oil that promotes storage stability, or both.Type: ApplicationFiled: April 29, 2005Publication date: April 23, 2009Inventors: Daniel Nestor Luchini, George K. Strohmaier, Eiler D. Frederiksen, James G. Hawkes, Bob J. Dull
-
Publication number: 20090098226Abstract: Composition in the form of a cosmetic formulation or dermatological medicament, suitable for maintaining skin cells at, or helping to restore skin cells to, their basal physiological state, enabling them to effect a regeneration of the dermis and the epidermis, comprising: —curcumin—a phosphosaccharide and possibly—a metal or basic oxide, or a biologically acceptable salt thereof, or a labile coordination compound thereof able to form, with at least one of said compounds: complexes, derivatives or associations which enhance their activity, in combination with excipients and/or diluents normally employed for cosmetic or pharmaceutical use.Type: ApplicationFiled: March 13, 2007Publication date: April 16, 2009Applicant: SCHARPER S.P.A.Inventors: Laura Martelli, Mario Martelli
-
Publication number: 20090093541Abstract: A melanin eliminator preparation comprising a metal chelate compound represented by the following formula (I), wherein M denotes a metal, and R denotes hydroxyl, O-lower alkyl, an amine bonded at N, an amino acid bonded at N, or a peptide bonded at N, or a pharmacologically acceptable salt thereof.Type: ApplicationFiled: December 3, 2008Publication date: April 9, 2009Applicant: OGA RESEARCH, INCInventor: Kazumi OGATA
-
Publication number: 20090088471Abstract: A chemical composition for use in controlling the population of free-roaming, sexually mature male dogs. The chemical sterilant is injected in a manner that the dog's appearance and secondary male sexual characteristics are preserved such that the dog maintains its position in the hierarchy of the free-roaming dogs while not contributing to the number of puppies produced. A reduction in the number of free-roaming dogs reduces the number of human victims of dog-bite acquired rabies. Because the appearance and nature of the sterilized dog is substantially unchanged, the chemical composition is acceptable to the human community that the dog habitats.Type: ApplicationFiled: September 28, 2007Publication date: April 2, 2009Inventor: Min Wang
-
Publication number: 20090081294Abstract: Aspects of the invention include a sustained release dosage form that can be administered to an oral cavity, e.g., the mouth. In certain embodiments, the sustained release dosage form is formulated as a lozenge or gum that may be administered to an oral cavity for the purpose of providing lubrication therein. In certain embodiments, the sustained release dosage form not only provides lubrication to a mucosal surface of an oral cavity, but also provides for the sustained release of a flavoring and/or beneficial agent. Accordingly, in certain embodiments, the sustained release dosage form includes a water-insoluble polymer, e.g., ethylcellulose, an essential oil component, and an effective amount of a film forming binder, e.g., xanthan gum.Type: ApplicationFiled: September 26, 2007Publication date: March 26, 2009Inventors: Jerry B. Gin, Benjamin F. Ross
-
Publication number: 20090074691Abstract: This invention relates to certain hydroxyaryl alkanols, alkyl amines, alkyl amino acids, alkyl amino esters, and alkyl amino alkanols (“Hydroxyaryl compounds”) of formula (I). A method of topical application of said hydroxyaryl compounds is also disclosed.Type: ApplicationFiled: November 29, 2008Publication date: March 19, 2009Applicant: BIODERM RESEARCHInventor: SHYAM K. GUPTA
-
Publication number: 20090074887Abstract: There are described new active compound combinations of a compound of the formula (I) with known fungicidal active compounds, and their use for the control of phytopathogenic fungi.Type: ApplicationFiled: May 9, 2008Publication date: March 19, 2009Applicant: Bayer CropScience AGInventors: Wilhelm Brandes, Heinz-Wilhelm Dehne, Stefan Dutzmann, Karl-Heinz Kuck, Bernd-Wieland Kruger
-
Patent number: 7497901Abstract: Complexes of copper and/or zinc with molybdate and/or tungstate were solubilized in ammonia or ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the complexes were stably retained in the wood providing a long lasting preservative.Type: GrantFiled: December 21, 2006Date of Patent: March 3, 2009Assignee: E. I. dupont de Nemours and CompanyInventors: Albert Gordon Anderson, John Feaster, Damini Patel, Mark Scialdone
-
Publication number: 20090041739Abstract: The present invention provides novel methods for treating a pulmonary disease state in mammals by up or down regulating indigenous in vivo levels of an inflammatory agent in mammalian cells comprising contacting the mammalian cells with a therapeutically effective amount of an inflammatory regulator, wherein the inflammatory agent is selected from the group consisting of cytokines, transforming growth factor-?, elastase, and white blood cells, and wherein the inflammatory regulator is selected from the group consisting of pyruvates and pyruvate precursors.Type: ApplicationFiled: January 22, 2008Publication date: February 12, 2009Inventor: Alain Martin
-
Publication number: 20090035393Abstract: The present invention relates to the use of pharmaceutically acceptable zinc salts, preferably water soluble zinc salts alone or optionally, in combination with one or more of a protein pump inhibitor (PPI), H2 blocker, anti-H. pylori antibiotic/antimicrobial, cytoprotective agent or a combination agent as otherwise described herein for providing fast action with optional long duration effect in reducing gastric acid secretion, raising the pH of the stomach during resting phase as well as decreasing the duration of stomach acid release during a secretagogue phase and for treating conditions including gastroesophageal reflux disease (GERD), non-erosive reflux disease (NERD), Zollinger-Ellison syndrome (ZE disease), ulcer disease, and gastric cancer, as well as preventing or reducing the likelihood of ulcer disease.Type: ApplicationFiled: January 25, 2007Publication date: February 5, 2009Inventors: John P. Geibel, Philipp Kirchhoff
-
Publication number: 20090035390Abstract: The present invention relates to methods and compositions which employ low concentrations of combinations of zinc salts and antimicrobial agents in coatings for medical articles. The coatings have an anti-irritant effect and inhibit transmission of infectious disease.Type: ApplicationFiled: June 2, 2006Publication date: February 5, 2009Inventors: Shanta M. Modak, Lauserpina Caraos, Carlo Micceri
-
Publication number: 20090022673Abstract: A comestible, water-based composition containing natural ingredients provides an effective amount of at least one active ingredient selected to reduce the proliferation of bacteria in the mouth of animals to treat and improve the dental health of animals. The composition can be administered to animals in the form of their daily intake of water and may be especially packaged for ready use and consumption by animals in pre-packaged and portable doses. Compositions containing natural ingredients and formulated as toothpastes for animal dental care are also provided.Type: ApplicationFiled: July 11, 2008Publication date: January 22, 2009Inventor: Karen L. Albert
-
Patent number: 7462369Abstract: Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating lesionous symptoms of a viral infection involving applying an effective amount of the anti-viral composition to the lesions.Type: GrantFiled: July 7, 2004Date of Patent: December 9, 2008Inventor: Jeffrey B. Smith
-
Patent number: 7462227Abstract: Complexes of ibuprofen and copper and/or zinc were solubilized in ammoniacal solution providing preservative solutions that fully penetrate wood. With loss of the ammonia from the wood, the complexes were stably retained in the wood providing a long lasting preservative.Type: GrantFiled: December 21, 2006Date of Patent: December 9, 2008Assignee: E.I. du Pont de Nemours and CompanyInventors: Albert Gordon Anderson, John Feaster, Damini Patel, Mark Scialdone
-
Publication number: 20080292674Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.Type: ApplicationFiled: May 19, 2008Publication date: November 27, 2008Inventor: Joseph J. Crudden
-
Publication number: 20080287536Abstract: This invention relates to certain skin and hair care agents of formula (I), derived from natural amino acids and peptides. These agents provide multi-functional treatment of enzyme-related topical problems, for example, darkened skin including age spots, circles around eyes and stretch marks; skin conditions related to acne including excess facial oil and facial pore size; premature hair aging including hair loss and graying; inflammation including intra-cellular and extra-cellular inflammation; skin aging including wrinkles and fine lines; loss of collagen including thinning skin and loss of skin pliability; malfunction of tyrosinase group of enzymes; malfunction of matrix metalloprotease group of enzymes; and combinations thereof: Wherein, R, R?, and R?=any substituent(s); and M=H, Li, Na, K, Ca, Mg, Zn, Mn, Cu, Fe, Co, Mo, V, Cr, Ammonium, Alkyl ammonium, and Nitrogen Heterocyclic ammonium.Type: ApplicationFiled: July 30, 2008Publication date: November 20, 2008Applicant: BIODERM RESEARCHInventor: SHYAM K. GUPTA
-
Patent number: 7449451Abstract: Disclosed herein is a method for protecting humans in need of such protection from physical damage caused by ionizing radiation comprising administering to said humans on a defined basis prior to and after exposure to such radiation a plurality of antioxidants at a dosage level directly proportional to the radiation level likely to be encountered.Type: GrantFiled: August 28, 2002Date of Patent: November 11, 2008Assignee: Premier Micronutrient CorporationInventors: Kedar N. Prasad, Gerald M. Haase, William C. Cole
-
Publication number: 20080275113Abstract: The present invention comprises an antimicrobial composition. More particularly to an antimicrobial composition that comprises a. from about 0.01% to about 15% of at least one non-anionic surfactant, by weight of the composition; b. from about 0.01% to about 15% of at least one acid, by weight of the composition; c. from about 0% to about 99.85% of water, by weight of the composition; and wherein the composition is foaming.Type: ApplicationFiled: May 2, 2008Publication date: November 6, 2008Inventors: Thomas Edward Huetter, Thomas Alfred Inglin, Timothy Woodrow Coffindaffer, Kelly Lee Martin, Brian Gilbert Leukart, Dennis Eugene Kuhlman
-
Publication number: 20080274209Abstract: Disclosed are compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating inflammatory symptoms and lesionous symptoms of a viral infection involving applying an effective amount of the pharmaceutical composition to the inflammation and lesions.Type: ApplicationFiled: July 15, 2008Publication date: November 6, 2008Inventor: Jeffrey B. Smith
-
Patent number: 7445799Abstract: An antimicrobial and chemical deactivating composition for use in a liquid medium or for incorporation into a coating, structural plastic materials, thin microporous membranes, textiles and sponges. The composition includes macrosize or submicron particles of silver, platinum with silver and their salts with parabens, oxide, salicylate, acetate, citrate, benzoate and phosphate along with copper and zinc salts of the same.Type: GrantFiled: June 21, 2001Date of Patent: November 4, 2008Assignee: ICET, Inc.Inventors: Shantha Sarangapani, Quoc T. Truong